R.H. Bluestein & Co’s Adient ADNT Stock Holding History

R.H. Bluestein & Co’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,000	Closed	-$252K	–	318
2017 Q3	$252K	Buy	+3,000	New	+$213K	0.01%	275

Other funds holding ADNT

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

KCM

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

R.H. Bluestein & Co's ADNT Position: Q4 2017 in Review

R.H. Bluestein & Co sold out of Adient (ADNT) in Q4 2017, closing a stake of 3,000 shares — an estimated $252K sold.

R.H. Bluestein & Co first reported a position in ADNT in Q3 2017 and held it in 1 quarter. The position peaked at $252K in Q3 2017. 450 funds tracked by Wall St. Rank hold ADNT as of Q4 2017.

R.H. Bluestein & Co reported no remaining Adient position as of Q4 2017 after selling out during the quarter.
R.H. Bluestein & Co sold 3,000 Adient shares in Q4 2017, an estimated $252K.
R.H. Bluestein & Co first reported a position in Adient in Q3 2017 and held it in 1 quarter.
R.H. Bluestein & Co's Adient position peaked at $252K in Q3 2017.
450 funds tracked by Wall St. Rank held Adient as of Q4 2017.

Based on R.H. Bluestein & Co's 13F filing for Q4 2017, filed 13 Feb 2018.